{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:11:30Z","timestamp":1750219890014,"version":"3.41.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":42,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070174"],"award-info":[{"award-number":["82070174"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.lrr.2025.100505","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T16:26:08Z","timestamp":1739809568000},"page":"100505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comprehensive analysis of Atypical chronic myeloid leukemia (aCML): Epidemiology, clinical features, and survival outcomes based on SEER database insights"],"prefix":"10.1016","volume":"23","author":[{"given":"Zhaoyang","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3278-4319","authenticated-orcid":false,"given":"Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.lrr.2025.100505_bib0001","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.lrr.2025.100505_bib0002","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.lrr.2025.100505_bib0003","series-title":"Precision Molecular Pathology of Myeloid Neoplasms","first-page":"213","article-title":"Atypical chronic myeloid leukemia, BCR\/ABL1 negative","author":"Levinson","year":"2018"},{"issue":"10","key":"10.1016\/j.lrr.2025.100505_bib0004","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1182\/blood-2013-05-500959","article-title":"The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment","volume":"122","author":"Gotlib","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.lrr.2025.100505_bib0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s12185-014-1670-3","article-title":"Molecular pathogenesis of atypical CML, CMML and MDS\/MPN-unclassifiable","volume":"101","author":"Zoi","year":"2015","journal-title":"Int. J. Hematol."},{"issue":"1","key":"10.1016\/j.lrr.2025.100505_bib0006","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ng.2495","article-title":"Recurrent SETBP1 mutations in atypical chronic myeloid leukemia","volume":"45","author":"Piazza","year":"2013","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.lrr.2025.100505_bib0007","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1182\/blood-2014-06-579466","article-title":"Recurrent ETNK1 mutations in atypical chronic myeloid leukemia","volume":"125","author":"Gambacorti-Passerini","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lrr.2025.100505_bib0008","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1182\/asheducation-2015.1.264","article-title":"What's different about atypical CML and chronic neutrophilic leukemia?","volume":"2015","author":"Dao","year":"2015","journal-title":"Hematology"},{"issue":"4","key":"10.1016\/j.lrr.2025.100505_bib0009","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/ajh.26828","article-title":"Atypical chronic myeloid leukemia and myelodysplastic\/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management","volume":"98","author":"Patnaik","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.lrr.2025.100505_bib0010","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1182\/hematology.2023000448","article-title":"Atypical CML: diagnosis and treatment","volume":"2023","author":"Breccia","year":"2023","journal-title":"Hematology"},{"key":"10.1016\/j.lrr.2025.100505_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.884723","article-title":"Allogeneic hematopoietic stem cell transplantation for mixed or overlap myelodysplastic\/myeloproliferative disorders","volume":"12","author":"Symeonidis","year":"2022","journal-title":"Front. Oncol."},{"issue":"17","key":"10.1016\/j.lrr.2025.100505_bib0012","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2014-02-553800","article-title":"Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic\/myeloproliferative neoplasms","volume":"123","author":"Wang","year":"2014","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.lrr.2025.100505_bib0013","first-page":"1566","article-title":"Identification of risk factors in atypical chronic myeloid leukemia","volume":"91","author":"Breccia","year":"2006","journal-title":"Haematologica"},{"issue":"16","key":"10.1016\/j.lrr.2025.100505_bib0014","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood.2019004229","article-title":"Molecular landscape and clonal architecture of adult myelodysplastic\/myeloproliferative neoplasms","volume":"136","author":"Palomo","year":"2020","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.lrr.2025.100505_bib0015","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2016-08-693630","article-title":"How I treat atypical chronic myeloid leukemia","volume":"129","author":"Gotlib","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.lrr.2025.100505_bib0016","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/ajh.27321","article-title":"Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management","volume":"99","author":"Szuber","year":"2024","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.lrr.2025.100505_bib0017","unstructured":"F. Breccia M Fau - Biondo, R. Biondo F Fau - Latagliata, I. Latagliata R Fau - Carmosino, F. Carmosino I Fau - Mandelli, G. Mandelli F Fau - Alimena, G. Alimena, Identification of risk factors in atypical chronic myeloid leukemia, (1592-8721 (Electronic))."},{"issue":"11","key":"10.1016\/j.lrr.2025.100505_bib0018","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1182\/blood.2019000611","article-title":"Genomic landscape of neutrophilic leukemias of ambiguous diagnosis","volume":"134","author":"Zhang","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lrr.2025.100505_bib0019","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-018-0774-4","article-title":"Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia","volume":"17","author":"Rocca","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lrr.2025.100505_bib0020","unstructured":"Surveillance, Epidemiology, and end results (SEER) program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Plus Data, 17 Registries, Nov 2022 Sub (2000-2020) - Linked To County Attributes - Time Dependent (1990-2021) Income\/Rurality, 1969-2021 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2023, based on the November 2022 submission."},{"key":"10.1016\/j.lrr.2025.100505_bib0021","unstructured":"Surveillance Research Program, National Cancer Institute SEER*stat software (seer.cancer.gov\/seerstat) version 8.4.3."},{"issue":"12","key":"10.1016\/j.lrr.2025.100505_bib0022","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.clml.2024.07.013","article-title":"Chronic myelomonocytic leukemia and Atypical Chronic myeloid leukemia: a national analysis","volume":"24","author":"Vardell","year":"2024","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.lrr.2025.100505_bib0023","article-title":"Characteristics and survival outcomes of patients with atypical chronic myeloid leukemia in the United States: a SEER-based analysis","volume":"20","author":"Ilerhunmwuwa","year":"2023","journal-title":"Leuk. Res. Rep"},{"issue":"2","key":"10.1016\/j.lrr.2025.100505_bib0024","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ajh.25688","article-title":"Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management","volume":"95","author":"Szuber","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.lrr.2025.100505_bib0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ajh.24253","article-title":"Myelodysplastic syndromes: contemporary review and how we treat","volume":"91","author":"Gangat","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.lrr.2025.100505_bib0026","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/ajh.23667","article-title":"Chronic neutrophilic leukemia 2014: update on diagnosis, molecular genetics, and management","volume":"89","author":"Elliott","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.lrr.2025.100505_bib0027","first-page":"233","article-title":"Characteristics and survival of patients with atypical chronic myeloid leukemia","volume":"54","author":"Kong","year":"2019","journal-title":"BR"},{"issue":"6","key":"10.1016\/j.lrr.2025.100505_bib0028","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.20035","article-title":"Association of age with treatment-related adverse events and survival in patients with metastatic colorectal cancer","volume":"6","author":"Meng","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"8","key":"10.1016\/j.lrr.2025.100505_bib0029","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/ajh.26984","article-title":"Myelodysplastic syndromes: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Garcia-Manero","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.lrr.2025.100505_bib0030","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1182\/bloodadvances.2022008204","article-title":"CNL and aCML should be considered as a single entity based on molecular profiles and outcomes","volume":"7","author":"Carre\u00f1o-Tarragona","year":"2023","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.lrr.2025.100505_bib0031","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034351","article-title":"Effect of time interval from diagnosis to treatment for non-small cell lung cancer on survival: a national cohort study in Taiwan","volume":"10","author":"Tsai","year":"2020","journal-title":"BMJ Open"},{"issue":"36","key":"10.1016\/j.lrr.2025.100505_bib0032","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1200\/JCO.2012.39.7695","article-title":"Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer","volume":"30","author":"McLaughlin","year":"2012","journal-title":"J. Clin. Oncol."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221304892500007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221304892500007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:15:13Z","timestamp":1750180513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221304892500007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":32,"alternative-id":["S221304892500007X"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2025.100505","relation":{},"ISSN":["2213-0489"],"issn-type":[{"type":"print","value":"2213-0489"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive analysis of Atypical chronic myeloid leukemia (aCML): Epidemiology, clinical features, and survival outcomes based on SEER database insights","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2025.100505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100505"}}